Skip to main content
Premium Trial:

Request an Annual Quote

Dow, Synpromics Collaborate on Synthetic Promoter Development

NEW YORK (GenomeWeb News) –Dow AgroSciences will develop synthetic promoter firm Synpromics' technology for applications in plant science under a collaboration announced today.

An initial proof of concept project with Dow Agro has begun to demonstrate the applicability of Synpromics' technology in certain crops, Synpromics said. Financial and other terms of the deal were not disclosed.

"Technologies such as those developed by Synpromics can significantly enhance Dow AgroSciences' tool kit for developing improved crops," Daniel Kittle, vice president of R&D for Dow AgroSciences, said in a statement. "Synthetic promoters in the agricultural industry have significant potential to accelerate the gene discovery and product development of new traits."

Based in Edinburgh, Scotland, Synpromics develops synthetic promoters for applications in diagnostics development, gene therapeutics, and research use. A synthetic promoter is a regulatory DNA sequence created by picking out the regulatory regions in a gene, chopping them up, and then putting them back together.

Filed under

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.